UAB Named Center Of Excellence In Treating Guillain-Barré Syndrome
By Bob Shepard
The University of Alabama at Birmingham has been named a Center of Excellence by the GBS/CIDP Foundation International for the diagnosis and treatment of Guillain-Barré Syndrome, chronic inflammatory demyelinating polyneuropathy and other inflammatory peripheral neuropathies. UAB becomes one of 44 global Centers of Excellence designated by the foundation.
Guillain-Barré Syndrome is an inflammatory disorder of the peripheral nerves outside the brain and spinal cord, characterized by the rapid onset of numbness, weakness and often paralysis of the legs, arms, breathing muscles and face. Paralysis is ascending, meaning that it travels up the limbs from fingers and toes toward the torso.
Please CLICK HERE to read the complete article on the Alabama NewsCenter website.
Category: ALL POSTS, Partner News Stories